Department of Ophthalmology, Duke University, Durham, North Carolina.
Department of Ophthalmology, Duke University, Durham, North Carolina; Department of Pediatrics, Duke University, Durham, North Carolina.
J AAPOS. 2021 Jun;25(3):177-180. doi: 10.1016/j.jaapos.2021.02.002. Epub 2021 May 6.
Guidelines on managing infants after initial anti-vascular endothelial growth factor (VEGF) treatment (eg, bevacizumab) for retinopathy of prematurity (ROP) are limited. We found that following initial bevacizumab treatment for ROP, prophylactically lasering infant eyes before hospital discharge reduced the number and duration of outpatient ROP screening examinations compared with following infants, per current United States (US) ROP screening guidelines.
早产儿视网膜病变（ROP）初始抗血管内皮生长因子（VEGF）治疗（如贝伐单抗）后婴儿管理指南有限。我们发现，与遵循美国现行 ROP 筛查指南相比，在初始贝伐单抗治疗 ROP 后，在出院前预防性地对婴儿眼睛进行激光治疗，可减少门诊 ROP 筛查检查的次数和持续时间。
